German pharma company MorphoSys's finance head to step down

Morphosys AG

20/12/2022 21:01

BERLIN, Dec 20 (Reuters) - German pharma company
MorphoSys  MORG.DE  said its finance chief Sung Lee would leave
the company for personal reasons in March 2023 and that the
company was seeking a successor to Sung, who joined in February
2021.
    The company suffered a major setback in November when an
Alzheimer's drug candidate it was developing with Roche failed
to slow the progress of the memory-robbing disease in two
separate drug trials.
    "We understand Sung's desire to go back to California and
the importance of his personal obligations," said company chair
Marc Cluzel.
 (Reporting by Thomas Escritt; editing by Barbara Lewis)
 ((thomas.escritt@thomsonreuters.com; @tomescritt;
@thomasescritt@berlin.social; +49 30 2201 33579;))